Lawrence Rice, MD
Dr. Lawrence Rice is Professor of Medicine in Hematology and Thrombosis Research. He has been Program Director of Hematology...
Read More
Elliott M. Antman, MD, FACC
Dr. Antman is director of the Samuel A. Levine Cardiac Unit in the Cardiovascular Division of the Brigham and Women's Hospital in Boston, Massachusetts.
Read More
Arthur Kavanaugh, MD
Dr. Kavanaugh is Professor of Medicine at The University of California at San Diego, School of Medicine and the Director of the Center for Innovative Therapy in Division of Rheumatology, Allergy and Immunology.
Read More
Hatim Omar, MD, FAAP
Dr. Omar is a Professor in Pediatrics and Obstetrics Gynecology and Director of Adolescent Medicine and Young Parent Program at the University of Kentucky in Lexington, Kentucky.
Read More
A discussion of the safety issues surrounding the use of biologic therapy is offered to clinicians to help support making critical treatment choice decisions. The occurrence of serious infectious episodes, serious post-operative infections, opportunistic infections, and malignancy with biologics compared with nonbiologic therapy will be discussed. Other areas of concern to be addressed include the use of biologics and their potential effect on neurologic and cardiovascular...
Read More
This activity presented by...
Marc D. Cohen, MD
Professor of Medicine
National Jewish Medical and Research Center,
Acute Respiratory Distress Syndrome (ARDS) affects thousands of hospitalized patients annually. Although many patients demonstrate some clinical criteria for ARDS the diagnosis is specific and should be made accurately. Likewise, many therapies for ARDS are based upon strong clinical evidence while others are more anecdotal and less well-established. This presentation will concisely summarize the epidemiology, diagnosis and evidence-based therapy for ARDS and is appropriate for hospitalists,...
Read More
This activity presented by...
Andrew C. Bernard, MD
Clinical Instructor of Surgery, Division of General Surgery
University of Kentucky Medical...
Transplantation is a unique therapeutic option for patients with end organ disease. The pharmacotherapy involved in the treatment of the transplant patient is often challenging. Immunosuppressive agents used have narrow therapeutic indices and have the potential for long term toxicity. More and more patients are transplanted every year. Community pharmacists will encounter this patient population at some point in their career. This program is designed to educate pharmacists on some of the...
Read More
This activity presented by...
Timothy Clifford, PharmD
Clinical Pharmacy Specialist, Transplant/Critical Care
University of Kentucky Medical Center,...
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice. Identification of immunosuppressive regimens that both reduce long-term immunosuppressive load, and minimize...
Read More
Almost 2,000,000 Americans are brain-injured every year and mortality and long-term morbidity from brain injury are common. Early aggressive emergency care, efforts to reduce secondary brain injury and rapid transfer to a trauma center are essential to optimize neurologic outcome. This presentation discusses epidemiology, diagnosis, stabilization, priorities of ICU care and potential complications which can arise in the brain-injured patient. This discussion is pertinent to all physicians,...
Read More
This activity presented by...
Andrew C. Bernard, MD
Clinical Instructor of Surgery, Division of General Surgery
University of Kentucky Medical...
This lecture focuses on the clinical presentation and measurements of disease activity of the spondyloarthropathies and on the available treatments. It is essential that clinicians stay abreast of the advances in these areas for optimal outcomes in the management of the spondyloarthropathies. Topics to be discussed include diagnostic criteria, assessment instruments, and current data on the efficacy of biologics in the treatment of psoriatic arthritis and ankylosing spondylitis.
Read More
This activity presented by...
Eric M. Ruderman, MD
Associate Professor
Division of Rheumatology
Northwestern University
Feinberg School of Medicine
To assist in the bringing about of optimal outcomes and improved quality of life in rheumatoid arthritis (RA) patients, this presentation addresses the potential comorbidities in patients with RA, the possible mechanisms for the increased risk of comorbidities in this population, and emerging data examining the impact of RA treatment on the occurrence and/or prevention of comorbidities.
Read More
This activity presented by...
Michael H. Weisman, MD
Professor of Medicine
UCLA School of Medicine, Division of Rheumatology
Department of Medicine...
In the United States, sepsis is the leading cause of death in non-coronary ICU patients, and the tenth most common cause of death overall according to data from the Centers for Disease Control and Prevention. Sepsis is common and also more dangerous in elderly, immunocompromised, and critically ill patients. It occurs in 1%-2% of all hospitalizations and accounts for as much as 25% of intensive care unit (ICU) bed utilization. It is a major cause of death in intensive care units worldwide,...
Read More
This activity presented by...
Philip A. Bernard, MD
Assistant Professor of Pediatrics
University of Kentucky
Kentucky Childrens Hospital
As confirmed by numerous reports and surveillance studies, multidrugresistant (MDR) Gram-negative pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii are increasing worldwide and pose a considerable public health threat, particularly among hospitalized patients. Data from the National Nosocomial Infections Surveillance (NNIS)System indicate that Gram-negative isolates are the most frequently reported pathogen (65.9%)associated with ICU-acquired pneumonia. Gram-negative...
Read More
